Letter to the Editor: Comparison of Lopinavir Level Between the Two Formulations (Soft-Gel Capsule and Tablet) in HIV-Infected Pregnant Women
- 1 August 2007
- journal article
- Published by Taylor & Francis in HIV Research & Clinical Practice
- Vol. 8 (4) , 254-255
- https://doi.org/10.1310/hct0804-254
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- The Tablet Formulation of Lopinavir/Ritonavir Provides Similar Bioavailability to the Soft-Gelatin Capsule Formulation With Less Pharmacokinetic Variability and Diminished Food EffectJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Plasma lopinavir trough levels in a group of pregnant women on lopinavir, ritonavir, zidovudine, and lamivudineAIDS, 2007